Skip to Content

'
Jeffrey H. Lee, MD, MPH, FASGE, FACG

Present Title & Affiliation

Primary Appointment

Professor, Department of Gastroenterology, Hepat,& Nutr, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Advanced Therapeutic Endoscopy Fellowship, Department of Gastroenterology, Hepat,& Nutr, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 1466
Houston, TX 77030
Phone: 713-794-5073
Fax: 713-563-4408

Education & Training

Postgraduate Training

1998-1999 Clinical Fellowship, Advanced Therapeutic Endoscopy, Harvard Medical School, Brigham and Women's Hospital, Boston, MA

Board Certifications

1998 American Board of Internal Medicine, Gastroenterology, Recertification Date: 2008

Selected Publications

Peer-Reviewed Original Research Articles

1. Sudo K, Wang X, Xiao L, Wadhwa R,Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath , Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. A nomagram to predict distant metastases after multimodality therapy of patients with localized esophageal cancer. JNCCN. In Press.
2. Krishna, SG, Lee JH. Appraisal of needle-based confocal laser endomicroscopy in the diagnosis of panacreatic cysts. World J Gastroenterol. In Press.
3. Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol. e-Pub 11/2015.
4. Krishna SG, Bhattacharya A, Li F, Ross WA, Ladha H, Porter K, Atiq M, Bhutani MS, Lee JH. Diagnostic Differentiation of Pancreatic Neuroendocrine Tumor from Other Neoplastic solid pancreatic lesions during endoscopic Ultrasound-guided Fine-Needle aspiration. Pancreas. e-Pub 9/2015.
5. Charalampakis N, Xiao L, ELilmova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standradized Uptake value of Positron Emission Tomorgraphy Influences the Prognosis of Patiens with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology. e-Pub 9/2015.
6. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajanji JA. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer. e-Pub 8/2015.
7. Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JA. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. Eur J Cancer. e-Pub 8/2015.
8. Ghouri YA, Krishna SG, Kundu UR, Bhutani MS, Lee JH, Ross WA. Erratum to: A case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to pancreas. Dig Dis Sci 60(7):2211, 7/2015. e-Pub 5/2015.
9. Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhuntani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endosc Ultrasound 3(219-24), 7/2015.
10. Litton JK, Lee JH, Arun BK. Reply to BRCA2-associated pancreatic cancer and current screening guidelines. Cancer. e-Pub 5/2015.
11. Shin EJ, Topazian M, Goggins MG, Syngal S, Saltzman JR, Lee JH, Farrell JJ, Canto MI. Linear-array EUS improves detecion of pancreatic lesions in high-risk individuals: a randomized tandem study. Gastrointest Endosc. e-Pub 4/2015.
12. Raju GS, Lum PH, Slack R, Thirumurthi SI, Lynch PM, Miller E, Weston BR, Davilia ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural Language Processing As an Alternative to Manual Reporting of Colonoscopy Quality Metrics. Gastrointest Endosc. e-Pub 4/2015.
13. Krishna SG, Bhattacharya A, Ross WA, Ladha H, Porter K, Bhutani MS, Lee JH. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration. J Gastroenterol Hepatol. e-Pub 4/2015.
14. Neishboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distributiion of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology 89(2):65-9, 3/2015.
15. Gavini H, Lee JH. Endoscopic Ultrasound-guided Endotherapy. J Clin Gastroenterol 49(3):185-93, 3/2015. e-Pub 12/2014.
16. Krishna S, Li F, Bhattacharya A, Ladha H, Porter K, Singh A, Ross WA, Bhutani MS, Lee, JH. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience. Gastro Endosc 81(2):370-9, 2/2015. e-Pub 10/2014.
17. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, SKinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma. Oncology 88(6). e-Pub 2/2015.
18. Cassani L, Lee JH. Management of Biliay Obstruction. Gastrointestinal Intervention. e-Pub 2/2015.
19. Ghouori YA, Krishna SG, Kundu UR, Bhutani MS, Lee JH, Ross WA. A Case Series and Literature Review of Merkel Cell Carcinoma Metastasizing to Pancreas. Dig Dis Sci. e-Pub 1/2015.
20. Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, Lee JH, Raju GS. Detection rates of premalignant polyps during screening colonoscopy: Time to revise quality standards? Gastrointest Endosc. e-Pub 1/2015.
21. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 23(3635-41), 120, 12/2014.
22. Eshleman JR, Norris AL, Sadakari Y, Debeljak M, Borges M, Harrington C, Lin E, Brant A, Brakley T, Almario JA, Topazian M, Farrell J, Syngal S, Lee JH J, Hruban RH, Kanda M, Canato MI, Goggins M. KRAS and GNAS Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound. Cllin Gastroenterol Hepatol. e-Pub 12/2014.
23. Gavini H, Arukala VD, Stweart J, Lee JH. Medulloblastoma Metastatic to the pancreas: a case report. Gastrointestinal Intervention 3(2):116-119, 12/2014.
24. Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, SKinner HD, Ajani JA. Importance of Surveillance and Success of Salvage Strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-5, 10/2014. e-Pub 9/2014.
25. Krishna SG, Rao BB, Thirumurthi S, Lee JH, Ramireddy S, Guindani M, Ross WA. Safety of endoscopic interventions in patients with thrombocytopenia. Gastrointest Endosc 80(3):425-34, 9/2014. e-Pub 4/2014.
26. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova EE, Song S, Ye Y, Huang M, AJani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer, 8/2014.
27. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol 9(8):1202-6, 8/2014.
28. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E. Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-44, 8/2014.
29. Song S, Ajani JA, Honjo S, Maru DM, Ailing S, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo Kazuki, Yao Y, Martin J, Hung MC, Johnson RL. The Hippo Coactivator YAP1 Upregulates SOX9 and Endows Cancer Stem Cell Properties in non-tumorigenetic cells and esophageal cancer cells. Cancer Res 74(15):4170-82, 8/2014. e-Pub 6/2014.
30. Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Maru DM, Blum MA, Ajani JA. Distribution and timing of distant metastasis after local therapy of patients with esophageal and esophagogastric junction cancer. Oncology 86((5-6)):336-339, 6/2014.
31. Krishna SG, Rao BB, Lee JH. Endoscopic sonography and sonographically guided fine-needle aspiration biopsy in the diagnosis of unusual pancreatic metastases from synovial sarcoma. J Clin Ultrasound 42(3):180-2, 3/2014. e-Pub 9/2013.
32. Ajani JA, Wang X, Song S, Sudo K, Wadhwa R, Hofstetter WL, Komak R, Dipen M, Lee JH, Bhutani M, Weston B, Baladandayuthapani V, Yao Y, Skinner H, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Molecular Oncology 8(1):142-9, 2/2014. e-Pub 10/2013.
33. Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21(1):306-14, 1/2014.
34. Shiozaki H, Sudo K, Xiao L, Wadhaw R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JA. Distribution and timing of distant metastsis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology 86(5-6):336-9, 2014.
35. Sudo K, Taketa T, Correa AM, Cahmpagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, SKinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 12/2013. PMCID: PMC3837091.
36. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh GL, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Dipen MM, Lee JH, Bhutani M, Eid A, Yao JC, Phan A, Halpin AK, Akihiro S, Taketa T, Thall PF, Swisher SG. A Phase 2 Randomized Trial of Induction Chemotherapy versus no induction Chemotherapy followed by preoperative chemoradiation in patients wiht esophageal cancer. Journal of Clinical Oncology 24(11):2844-9, 11/2013. e-Pub 8/2013. PMCID: PMC3937600.
37. Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmu J, Swisher SG, Hofstetter WL, Ajani JA. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma in Patients who achieve a clinical complete response after chemoradiation. Annals of Oncology 24(1):2854-9, 11/2013. e-Pub 8/2013.
38. Wadhwa R, Taketa T, Correa A, Sudo K, Campagna MC, Blum Murphy M, Komaki R, Skinner H, Lee JH, Bhutani M, Weston B, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance. Oncology 85(4):204-207, 9/2013.
39. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehra RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL. The influence of histopathologic tumor viability on Long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg 258(3):500-7, 9/2013.
40. Taketa T, Xiao L, Suzuki A, Wadhwa R, Blum M, Lee JH, Weston B, Bhutani M, Skinner H, Komaki R, Maru D, Rice D, Swisher S, Hofstetter W, Ajani JA. Propensity-based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation. Oncology 85(2):95-99, 7/2013.
41. Kochar R, Atiq M, Lee JH, Landon G, Mansfield PF,Bhutani MS. Giant Hepatic Hemangioma masquerading as a gastric subepithelial tumor. Gastroenterol Hepatol 9(6):396-8, 6/2013. PMCID: PMC3736798.
42. Suzuki R, Lee JH, Krisha SG, Ramireddy S, Qiao W, Weston B, Ross WA, Bhutani MS. Repeat endoscopic ultrasound-guided fine needle aspiration for solid pancreatic lesions at a tertiary referral center will alter the initial inconclusive result. J Gastrointestin Liver Dis 22(2):183-7, 6/2013.
43. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Takta T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: Analysis in a large cohort. Ann Oncol 24(5):1262-6, 5/2013. e-Pub 12/2012. PMCID: PMC3629896.
44. Atiq M, Suzuki R, Khan AS, Krishna SG, Ridgway TM, Guha S, Hernandez LV, Nealon WH, Lee JH, Bhutani MS. Clinical decision making in the management of pancreatic cystic neoplasms. Expert Rev Gastroenterolo Hepatol 7(4):353-60, 5/2013.
45. Atiq M, Bhutani MS, Ross WA, Raju GS, Gong Y, Tamm EP, Javle M, Wang X, Lee JH. Role of Endoscopic Ultrasound in Evaluation of Metastatic Lesions to the Pancreas: A tertiary cancer center experience. Pancreas 42(3):516-23, 4/2013. e-Pub 12/2012.
46. Lee JH, Krishna SG, SinghA, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 78(2):312-24, 2013.
47. Wang W, Shpaner A, Krishna SG, Ross WA, Bhutani MS, Tamm EP, Raju GS, Xiao L, Wolff RA, FLeming JB, Lee JH. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc 78(1):73-80, 2013.
48. Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer 48(18):3396-404, 12/2012.
49. Singh A, Ross W, Bhattacharya A, Xiao L, Dekovich A, Davila M, Raju G, Lee JE, Fleming JB, Lee JH. Gastrojejunostomy vs. enteral self-expanding metal stent placement in patients with malignant gastric outlet obstruction. Gastrointest Intervention 3(4):304-5, 12/2012. PMCID: PMC3492472.
50. Singh A and Lee JH. Self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. Journ of Gastrointest Oncology 3(4):304-5, 12/2012. PMCID: PMC3492472.
51. Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Surveillance for esophageal cancer: does it make sense? J Natl Compr Canc Netw 10(12):1590-2, 12/2012.
52. Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of the Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium Summit on the Managment of Patients with Increased Risk for Familial Pancreatic Cancer. Gut. e-Pub 11/2012.
53. Kanda M, Sadakri Y, Borges M, Topazian M, Farrell J, Syngal S, Lee J, Kamel I, Lennon AM, Knight S, Fujiwar S, Hruban RH, Canto MI, Goggins M. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clinical Gastroenterology and Hepatology S1542-3565(12):1413-9, 11/2012.
54. Ajani AJ, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru M, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical Parameters Model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 23(10):2638-42, 10/2012. e-Pub 7/2012.
55. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Change J, Maru D, Lee JH, Ajani JA, Swisher SG. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg 94(4):1126-32, 10/2012. e-Pub 8/2012.
56. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Ross WA, Rice DC, Vaporciyan AA, Swisher SG, Hofstetter WL, Ajani JA. Outcome of Trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology 83(5):300-4, 9/2012.
57. Kanda M, Knight S, Topazian MD, Syngal S, Farrell J, Lee JH, Kamel I, Lennon AM, Borges M, Young A, Fujiwara S, Seike J, Eshleman J, Hruban RH, Canto M, Goggins. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut, 8/2012. e-Pub 8/2012.
58. Saftoui A, Bhutani MS, Vilmann P, Surlin V, Uthamanthil RK, Lee JH, Bektas M, Singh H, Ghenonea DI, Patrascu S, Gupta V, Katz MH, Fleming JB. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Hepatogastroenterology 6(60):121, 7/2012.
59. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 50(3):407-28, 5/2012. e-Pub 4/2012.
60. Canto MI, Hruban RR, Fishman EK, Kamel IR, Schulick R, Zhang A, Topazian M, Takahashi N, Fltcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, VIkram R, Bhosale P, Margolis D, Farrell J, Goggins M. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 4/2012.
61. Kountourakis P, Ajani JA, Davila M, Lee JH, Bhutani MS, Izzo JG. Barrett's esophagus: a Review of biology and therapeutic approaches. Gastrointest Cancer Res 5(2):49-57, 3/2012.
62. Atiq M, Gong Y, Raju GS, Lee JH. Pancreatic Endocrine Microadenomatosis in a patient with oculofaciocardiodental (OFCD) syndrome. Pancreas 41(2):327-9, 3/2012. PMID: 22343980.
63. Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MS. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers; a systematic review and meta-analysis. Gastrointest Endosc 75(2):242-53, 2/2012. e-Pub 11/2011.
64. Harvin JA, Lahat G, Correa AM, Lee, JH, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehra R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinioma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2/2012.
65. Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, AJani JA. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 82(2):108-113, 2/2012. PMID: 22328056.
66. Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z, Topazian M, Takahashi N, Fletcher J, Petersen G, Klein AP, Axilbund J, Griffin C, Syngal S, Saltzman JR, Mortele KJ, Lee JH, Tamm E, Vikram R, Bhosale P, Margolis D, Farrell J, Goggins M. American Cancer of the Pancreas screening (CAPS) consortium, frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796-804, 2012. PMCID: PMC3321068.
67. Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh H. Celiac Node Failure Patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-9, 2012. e-Pub 3/2012. PMCID: PMC3795392.
68. Lee JH, Singh A. Difficult endoscopic retrograde cholangiopancreatography in cancer patients. Gastrointest interv 1:19-24, 2012.
69. Jaganmohan S, Lynch PM, Raju RM, Ross WA, Lee JE, Raju GS, Bhutani MS, Fleming JB, Lee JH. Endoscopic management of duodenal adenomas in familial adenomatous polyposis- A single center experience. Dig Dis Sci 57(3):732-7, 2012. e-Pub 9/2011.
70. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA pancreatic neuroendocrine Tumors: A tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 2012. e-Pub 10/2011.
71. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized gastric cancer treated with chemoradion without surgery: UTMD Anderson Cancer Center experience. Oncology 82(6):347-51, 2012.
72. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus 25(7):614-22, 2012.
73. Jaganmohan S, Lee JH. Self-expandable metal stents in malignant biliary obstruction. Expert Review. Gastroenterology & Hepatology 6(1):105-14, 2012.
74. Singal AK, Ross WA, Guturu P, Varadhachary G, Javle M, Jaganmohan S, Raju R, Fleming J, Raju GS, Kuo YF, Lee JH. Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: Single-center experience with 79 cases. Dig Dis and Sci 56(12):3678-84, 12/2011. e-Pub 7/2011.
75. Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JA. Prognostic significance of baseline positron emission tonography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 117(21):4823-33, 11/2011. e-Pub 3/2011.
76. Krishna S, Lee JH. Endosonographpy in solid and cystic pancreatic tumors. Journal of Interventional Gastroenterology 1(4):193-201, 10/2011. PMCID: PMC3350895.
77. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS, Wang X, Lee JH. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 57(3):791-800, 10/2011.
78. Ioncica AM, Atiq M, Lee JH, Saftoiu A, Bhutani MS. Gastric and pancreatic metastases from pleomorphic lung carcinoma. Endoscopy 43(Suppl 2):E317-8, 10/2011. e-Pub 10/2011.
79. Kim HN, Alouis AM, Lee JH, Qiao W, Xiao L, Ross WA. Role of ERCP in patients after hematopoietic stem cell transplantation. Gastrointest Endosc 74(4):817-24, 10/2011. e-Pub 7/2011.
80. Estrella JS, Hofstetter WL, Correa A, Swisher SG, Ajani JA, Lee JH, Bhutani M, Abraham S, Rashid A. Duplicated muscularis mucosa invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am journ of surg path 35(7):1045-53, 7/2011.
81. Raju RP, Jaganmohan SR, Ross WA, Davila M, Javle M, Raju GS, Lee JH. Optimal palliation of inoperable hilar cholangiocarcinoma: Comparative assessment of the efficacy of plastic and self-expanding metal stents. Dig Dis and Sci 56(5):1557-64, 5/2011. e-Pub 1/2011. PMID: 212221566.
82. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined Modality Therapy of cT2N0M0 Esophageal Cancer: UT MD Anderson Cancer Center Experience. Cancer 117(5):925-30, 3/2011. e-Pub 10/2010.
83. Lee JH. Self-expandable metal stents for malignant distal biliary strictures. Gastrointest Endoscopy Clin N Am(21):463-480, 2011.
84. Welsh J, Amini A, Likhacheva A, Erasmus JJ, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee JH, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep 13(3):157-67, 2011.
85. Weston BR, Ross WA, Liu J, Lee JH. Clinical outcomes of nitinol and stainless steel uncovered metal stents for malignant biliary strictures. Is there a difference? Gastrointest Endosc 72(6):1195-200, 12/2010.
86. Lee JH, Ross WA, Davila R, Chang G, Lin E, Dekovich A, Davila M. Self-expandable metal stents (SEMS) can serve as a bridge to surgery or as a definitive therapy in patients with an advanced stage of cancer: Clinical experience of a tertiary cancer center. Dig Dis Sci 55(12):3530-6, 12/2010. e-Pub 8/2010.
87. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of High Body Mass Index on Prognosis of Patients with Esophageal Carcinoma Following Surgery as Primary Therapy. Cancer 116(24):5619-27, 12/2010.
88. Ross WA, Egwin CI, Wallace MJ, Wang M, Madoff D, Lee JH. Outcomes in Lymphoma patients with obstructive jaundice: a cancer center experience. Dig Dis and Sci 55(11):3271-7, 11/2010. e-Pub 7/2010.
89. Kim SM, Park YY, Park ES, Cho JY, Izzo JG, Zhang D, Kim SB, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee JS. Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome. PLoS One 5(11), 11/2010.
90. Atiq M, Javle M, Dang S, Lee JH. Cholangiocarcinoma: an endoscopist's perspective. Expert Rev Gastroenterol Hepatol 4(5):601-11, 10/2010.
91. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group (Ajani JA, Lee JH, et al.) and the University of Rochester School of Medicine and Dentistry Foregut Group. Endoscopic Esophageal Tumor Length: A Novel Prognostic Factor for Esophageal Cancer Patients. Cancer 252(4):611-7, 10/2010. e-Pub 8/2010.
92. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. Genome-wide catalogue of chromosomal aberrations in Barrett's esophagus and esophageal adenocarcinoma: A high-density single nucleotide polymorphism array analysis. Cancer Prev Res (phila PA) 3(9):1176-86, 9/2010. e-Pub 8/2010.
93. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, and Ajani JA. Improved Long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8, 9/2010.
94. Kim MP, Correa AM, Lee JH, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-89, 9/2010.
95. Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. The Standardized uptake value of 18-Fluoro-deoxy-glucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroenterology carcinoma. Oncology 78 (5-6):316-322, 8/2010.
96. Katz MH, Varadhachar GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradtion. Ann Surg Oncol 17(7):1794-801, 7/2010.
97. Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA. Multimodality approaches to localized gastric cancer. J Natl Compr Canc Netw 8(4):417-25, 4/2010.
98. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/2010.
99. Weston BA, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of Integrated Positron Emission and Computed Tomography to Detect Significant Colonic Pathology: The Experience of a Tertiary Cancer Center. Cancer 116(6):1454-61, 3/2010.
100. Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA. Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer 116(19):4487-94, 2010.
101. Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, and Ajani JA. Higher the Decrease in the Standardized Uptake Value of Positron Emission Tomography after Chemoradiation Better the Survival of Patients with Gastroesophageal Adenocarcinoma. Cancer 115(22):5184-92, 11/2009.
102. Bhutani MS, Verma D, Guha S, Lee JH, Richards-Kortum RR, Fleming JB. Is Endoscopic Ultrasound "Sound" for Pancreatic Cancer Screening? J Clin Gastroenterol 43(9):797-802, 10/2009. PMID: 19652621.
103. Leung KK, Ross WA, Evans D, Fleming J, Lin E, Tamm EP, Lee JH. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. Ann Surg Oncol 16(10):2818-24, 10/2009. e-Pub 6/2009. PMID: 19536601.
104. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez C, Lee JH, Hofstetter W, Marom EM, Mehran R, Vaporicyan A, Walsh G, Swisher S. Endobronchial ultrasound guided needle biopsy for staging of malignant pleural mesothelioma. The Annals of Thoracic Surgery 88(3):862-8, 9/2009.
105. Lee JH, Stewart J, Ross WA, Anandasabapathy S, Xiao L, Staerkel G. Blinded Prospective Comparison of the Performance of 22-gauge and 25-gauge needles in Endoscopic Ultrasound-Guided Fine Needle Aspiration of the Pancreas and Peri-pancreatic lesions. Dig Dis Sci 54(10):2274-81, 8/2009.
106. Lagaly R, Horak A, Lee JH, Mansfield PF, Ajani JA. Patient with advanced gastric cancer responds twice to the same systemic therapy. Gastrointest Cancer Res 3(3):115-7, 3, 5/2009.
107. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-630, 2/2009.
108. Cen P, Correa AM, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009.
109. Izzo JG, Wu X, Wu TT, Huan P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JA. Therapy-induced Expression of NF-kB Portends Poor Prognosis in Patients with Localized Esophageal Cancer Undergoing Preoperative Chemoradiation. Dis Esophagus 22(2):127-32, 2009.
110. Ross WA and Lee JH. Endoscopic Approach to Tracheoesophageal Fistulas in Adults. Techniques in Gastrointestinal Endoscopy 10(4):155-163, 10/2008.
111. Ross WA, Wasan SM, Evans DB, Wolff RA, Trapani LV, Staerkel GA, Prindiville T, Lee JH. Combined endoscopic ultrasound with fine-needle aspiration and endoscopic retrograde cholangiopancreatography in the evaluation of patients presenting with obstructive jaundice from presumed pancreatic malignancy. Gastrointest Endosc 68(3):461-6, 9/2008.
112. Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Zhongzing L, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani, JA. Influence of Induction Chemotherapy and Class of Cytotoxics on Pathologic Response and Survival After Preoperative Chemoradiation in Patients with Carcinoma of the Esophagus. Cancer 113(6):1302-8, 15, 9/2008.
113. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-20, 7/2008.
114. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Tamm EP, Wang H, Lee JE, Pisters PWT, Vauthey JN, Abdalla E, Lee JH, Ho L, Staerkel GA, Bhosale PR, Ross WA, Krishnan S, Xiong H, Das P, Abbruzzese JL, Evans DB. Preoperative Gemcitabine and Cisplatin followed by Gemcitabine-based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head. J Clin Oncol 26(21):3487-95, 7/2008.
115. Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 15(5):1356-66, 5/2008.
116. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davila M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Lymphovascular Invasion as a Tool to Further Subclassify T1b Esophageal Adenocarcinoma. Cancer 112:1020-1027, 1/2008.
117. Ross WA, Ghosh S, Dekovich AA, Liu S, Ayers GD, Cleary KR, Lee JH, Couriel D. Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies. Am J Gastroenterol 103(4):982-9, 2008.
118. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: How soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer 112(11):2417-23, 2008. PMID: 18404695.
119. Tamm EP, Bhosale PR, Lee JH. Pancreatic Ductal Adenocarcinoma: Ultrasound, Computed Tomography, and Magnetic Resonance Imaging Features. Seminars in Ultrasound CT and MRI 28:330-338, 10/2007.
120. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PW, Feig B, Sunder PK, Izzo JG, Ajani JA. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 110(5):989-95, 9/2007.
121. Izzo JG, Luthra R, Sims-Mourtada J, Chao KS, Lee JH, Wu TT, Correa AM, Luthra M, Aggarwal B, Hung MC, Ajani JA. Emerging molecular targets in esophageal cancers. Gastrointest Cancer Res 1(4 (suppl 2)):S3-6, 7/2007.
122. Ross WA, Alkassab F, Lynch PM, Ayers GD, Ajani J, Lee JH, Bismar M. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc 65:70-6, 1/2007. PMID: 17185082.
123. Northrop JA, Lee JH. Large bowel carcinoid tumors. Curr Opin Gastroenterol 23:74-8, 1/2007. PMID: 17133089.
124. Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of Endoscopic Ultrasound Staging in Conjunction with the Evaluation of Lymphovascular Invasion in Identifying Low-Risk Esophageal Carcinoma. Cancer 112(3):503-10, 2007. e-Pub 12/2007.
125. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thoracic Oncol 1(5):478-486, 6/2006.
126. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13(4):582-94, 4/2006. PMID: 16523362.
127. Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 24(5):748-54, 2/2006. PMID: 16401681.
128. Luthra R, Wu TT, Luthra MG, Izzo J, Lopez-Alvarez E, Zhang L, Bailey J, Lee JH, Bresalier R, Rashid A, Swisher SG, Ajani JA. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24(2):259-67, 1/2006. PMID: 16344314.
129. Fukami N, Lee JH. Endoscopic treatment of large sessile and flat colorectal lesions. Curr Opin Gastroenterol 22(1):54-9, 2006. PMID: 16319677.
130. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
131. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19:152-7, 2006. PMID: 16722991.
132. Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW. Intraductal papillary mucinous neoplasms of the pancreas. Med Princ Pract 15:245-52, 2006. PMID: 16763389.
133. Mullen JT, Wang H, Yao JC, Lee JH, Perrier ND, Pisters PW, Lee JE, Evans DB. Carcinoid tumors of the duodenum. Surgery 138(6):971-7; discussion 977-8, 12/2005. PMID: 16360380.
134. Lee JH. Interventional gastroenterology: esophageal and pancreatic cancers. Semin Oncol 32(6 Suppl 8):25-8, 12/2005. PMID: 16360009.
135. Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9(8):1094-104; discussion 1104-5, 11/2005. PMID: 16269380.
136. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patients with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-6, 10/2005. PMID: 16118804.
137. Wasan SM, Ross WA, Staerkel GA, Lee JH. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 100(9):2056-61, 9/2005. PMID: 16128952.
138. Evans DB, Lee JH, Crane CH. Authors response regarding letter to the editor from JP Hoffman concerning: Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey J-N, Lee JE, Pisters PWT, Evans DB. J Gastrointest Surg 9 (8):1104-1105, 2005.
139. Aslanian H, Salem R, Lee JH, Andersen D, Robert M, Topazian M. EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 100:1381-1385, 2005.
140. Aslanian H, Salem R, Lee JH, Robert M, Topazian M. EUS guided ethanol injection of normal porcine pancreas: A pilot study. Gastrointest Endosc 62:723-727, 2005.
141. Aspelund G, Topazian MD, Lee JH, Andersen DK. Improved outcomes with limited pancreatic head resections for benign disease. J Gastrointest Surg 9(3):400-409, 2005.
142. Prasad P, Salem RR, Mangla R, Aslanian H, Jain D, Lee JH. Lymphoplasmacytic Sclerosing Pancreatitis: A Case Report. Yale J Biol Med 77:143-148, 2005.
143. Sheehan S, Lee JH, Wells CK, Topazian M. Serum Amylase, Pancreatic Stents, and Pancreatitis After Sphincter of Oddi Manometry. Gastrointest Endosc 62(2):260-265, 2005.
144. Lee JH, Salem R, Aslanian H, Chacho M, Topazian M. Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures. Am J Gastroenterol 99(6):1069-1073, 2004.
145. Lee JH, Topazian M. Pancreatic endosonography after Billroth II gastrectomy. Endoscopy 36(11):972-975, 2004.
146. Hong-Curtis J, Yeh MM, Jain D, Lee JH. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis. J Clin Gastroenterol 38(10):906-909, 2004.
147. Lee JH. Longitudinal Endosonograpy. J Clin Gastroenterol 34:196, 2002.
148. Yim HB, Jacobson BC, Saltzman JR, Johannes RS, Bounds BC, Lee JH, Shields SJ, Ruymann FW, Van Dam J, Carr-Locke DL. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 53(3):329-32, 2001.
149. Jacobson BC, Hirshch MS, Lee JH, Van Darn J, Shoji B, Farraye F. Multiple asymptomatic plexiforrn schwannomas of the sigmoid colon: a case report and review. Gastrointest Endosc 53:801-804, 2001.
150. Ajani, JA, Izzo J, Wang X, Chao C, Wu, TT, Malhotra, U, Vaporciyan AA, Lee JH, Bhutani M, Liao Z, Lee, JS, Wu, X, Berry D. Biomarker Signature that is highly predictive of pathologic complete response in patients with gastroesophageal adenocarcinoma undergoing preoperative chemoradiation. Journ of Clin Onc. Submitted.
151. Krishna S, Rao B, Lee JH, Ramireddy S, Guindani M, Ross WA. Safety, necessity of standard endoscopic interventions, and management of gastrointestinal bleeding in patients with thrombocytopenia. Amer Journ of Gastroenterol. Submitted.

Invited Articles

1. Lee JH, Neuduck B. The Continuum of Patient Care Related to Acid Suppression. Pharmacy Practice News, Gastroenterology and Endoscopy News, 12/2003.
2. Lee JH. Endoscopic Management of Gastroesophageal Reflux Disease. American College of Gastroenterology 2003 Highlights, 2003.

Editorials

1. Singh A, Lee JH. self-expanding metal stents for preoperative biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer. J Gastrointest Oncol 3(4):304-5, 12/2012. PMCID: PMC3492472.
2. Lee JH. Is combination biliary sphincterotomy and balloon dilation a better option than either alone in endoscopic removal of large bile-duct stones? Gastrointest Endosc 66(4):727-729, 10/2007.

Book Chapters

1. Bhosale P, Fleming J, Das P, Javle M, Lee JH. Cystic Pancreatic Lesions. In: Oncologic Imaging. Ed(s) Paul Silverman. Bermedica Production, Ltd. Columbia, MD, 1-19, 2012.
2. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability. In: Radiologic CLinics of North America. 50. Ed(s) Miller FM, Morgan DE, Mortele KJ. WB Saunders, 407-428, 2012.
3. Lee JH, Kelsey P. Choledochoscopy and Pancreatoscopy. In: Successful training in gastrointestinal endoscopy. Ed(s) Cohen J. Wiley-Blackwell: New York, 116-124, 2011.
4. Lee JH, Tamm EP. Pancreatic Carcinoma: Detection and Staging. In: EUS Pathology with Digital anatomy Correlation. People's Medical Publishing House: Shelton, CT, 149, 2010.
5. Javle M, Abernethy A, Busaidy NL, Lee JH. Dilemmas in upper gastrointestinal cancers, focus on symptom improvement. In: 2009 ASCO Educational Book, 2009.
6. Yendamuri S, Lee JH, Rice DC. Malignant: Metastatic. In: Esophageal Cancer Principles and Practice. Ed(s) Jobe BA, Thomas CR, Hunter JG. demosmedical, 355-359, 2009.
7. Lee JH, Ross WA. Invasive/Interventional Gastroenterology. In: Medical Care of Cancer Patients. Ed(s) Yeung SJ, Escalante C, Gagel R. BC Decker, 2008.
8. Lee, JH, Wolf J. Complications of IBD, 61. In: Osteopenia and Osteoporosis: Prevention and Treatment, Advanced Therapies in Inflammatory Bowel Disease, P289-292, 2000.

Letters to the Editor

1. Litton JK, Lee JH, Arun BK. BRCA2 associated pancreatic cancer and current screening guidelines. Cancer. e-Pub 5/2015.
2. Lee JH, Paterson J, Greisman H, Jacobsen D, Farraye F. Asymptomatic Ileal Carcinoid Detected During Colonoscopy. Am J Gastroenterol 95:851-852, 2000.
3. Atiq M, Lee JH. Pancreatic Endocrine Microadenomatosis in a patient with ocul-facio-cardio-dental syndrome (OFCD). Pancreas. Submitted.

Last updated: 2/24/2016